Mizuho Lifts Price Target on Amylyx Pharmaceuticals to $21 From $19, Maintains Outperform Rating
Idag, 18:12
Idag, 18:12
12:12 PM EDT, 04/29/2026 (MT Newswires) -- Amylyx Pharmaceuticals (AMLX) has an average rating of buy and mean price target of $23.30, according to analysts polled by FactSet.
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
Price: 15.76, Change: -0.55, Percent Change: -3.37
Idag, 18:12
12:12 PM EDT, 04/29/2026 (MT Newswires) -- Amylyx Pharmaceuticals (AMLX) has an average rating of buy and mean price target of $23.30, according to analysts polled by FactSet.
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
Price: 15.76, Change: -0.55, Percent Change: -3.37
Rapporter
Analys
Rapporter
Analys
1 DAG %
Senast
OMX Stockholm 30
−0,51%
(vid stängning)
Federal Reserve
Idag, 20:07
Fed lämnar räntan oförändrad
OMX Stockholm 30
1 DAG %
Senast
3 040,54